Literature DB >> 25477278

3D model-based documentation with the Tumor Therapy Manager (TTM) improves TNM staging of head and neck tumor patients.

Thomas Pankau1,2, Gunnar Wichmann1, Thomas Neumuth3, Bernhard Preim4, Andreas Dietz1,3, Patrick Stumpp5, Andreas Boehm6.   

Abstract

PURPOSE: Many treatment approaches are available for head and neck cancer (HNC), leading to challenges for a multidisciplinary medical team in matching each patient with an appropriate regimen. In this effort, primary diagnostics and its reliable documentation are indispensable. A three-dimensional (3D) documentation system was developed and tested to determine its influence on interpretation of these data, especially for TNM classification.
METHODS: A total of 42 HNC patient data sets were available, including primary diagnostics such as panendoscopy, performed and evaluated by an experienced head and neck surgeon. In addition to the conventional panendoscopy form and report, a 3D representation was generated with the "Tumor Therapy Manager" (TTM) software. These cases were randomly re-evaluated by 11 experienced otolaryngologists from five hospitals, half with and half without the TTM data. The accuracy of tumor staging was assessed by pre-post comparison of the TNM classification.
RESULTS: TNM staging showed no significant differences in tumor classification (T) with and without 3D from TTM. However, there was a significant decrease in standard deviation from 0.86 to 0.63 via TTM ([Formula: see text]). In nodal staging without TTM, the lymph nodes (N) were significantly underestimated with [Formula: see text] classes compared with [Formula: see text] with TTM ([Formula: see text]). Likewise, the standard deviation was reduced from 0.79 to 0.69 ([Formula: see text]). There was no influence of TTM results on the evaluation of distant metastases (M).
CONCLUSION: TNM staging was more reproducible and nodal staging more accurate when 3D documentation of HNC primary data was available to experienced otolaryngologists. The more precise assessment of the tumor classification with TTM should provide improved decision-making concerning therapy, especially within the interdisciplinary tumor board.

Entities:  

Keywords:  Documentation; Head and neck cancer; Panendoscopy; Patient data; Reproducibility; TNM staging; Three-dimensional; Tumor Therapy Manager

Mesh:

Year:  2014        PMID: 25477278     DOI: 10.1007/s11548-014-1131-8

Source DB:  PubMed          Journal:  Int J Comput Assist Radiol Surg        ISSN: 1861-6410            Impact factor:   2.924


  10 in total

1.  Complete fully automatic model-based segmentation of normal and pathological lymph nodes in CT data.

Authors:  Lars Dornheim; Jana Dornheim; Ivo Rössling
Journal:  Int J Comput Assist Radiol Surg       Date:  2010-10-08       Impact factor: 2.924

2.  Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites.

Authors:  Maria Blomberg; Ann Nielsen; Christian Munk; Susanne Krüger Kjaer
Journal:  Int J Cancer       Date:  2010-10-26       Impact factor: 7.396

3.  Multidisciplinary team a prerequisite in the management of head and neck cancer?

Authors:  Jan Olofsson
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-02       Impact factor: 2.503

4.  Integrated media presentation in multidisciplinary head and neck oncology meetings.

Authors:  Ricard Simo; Peter Morgan; Jean-Pierre Jeannon; Edward Odell; John Harrison; Bernice Almeida; Mark McGurk; Andrew Lyons; Karim Hussain; Michael Gleeson; Mary O'Connell; Frances Calman; Roy Ng; Paul Roblin; Steve Connor; Michael Fenlon; Mary Burke; Ashish Chandra; Amanda Herbert; Sarah Patt; Lizzie Steward-Bagley; Rachael Donnelly; Lesley Freeman; Claire Twinn; Carolyn Mason
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-12-05       Impact factor: 2.503

5.  Different approaches to volume assessment of lymph nodes in computer tomography scans of head and neck squamous cell carcinoma in comparison with a real gold standard.

Authors:  Stefan Mueller; Gunnar Wichmann; Lars Dornheim; Ivo Roessling; Julia Bertolini; Bernhard Preim; Andreas Dietz; Andreas Boehm
Journal:  ANZ J Surg       Date:  2012-09-09       Impact factor: 1.872

Review 6.  Head and neck cancer: changing epidemiology, diagnosis, and treatment.

Authors:  Shanthi Marur; Arlene A Forastiere
Journal:  Mayo Clin Proc       Date:  2008-04       Impact factor: 7.616

7.  Impact of indication-shift of primary and adjuvant chemo radiation in advanced laryngeal and hypopharyngeal squamous cell carcinoma.

Authors:  A Boehm; F Lindner; G Wichmann; U Bauer; C Wittekind; M Knoedler; F Lordick; S Dietzsch; M Scholz; R Kortmann; A Dietz
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-25       Impact factor: 2.503

Review 8.  Multidisciplinary management of locally advanced SCCHN: optimizing treatment outcomes.

Authors:  K Kian Ang
Journal:  Oncologist       Date:  2008-08-13

Review 9.  Current aspects of targeted therapy in head and neck tumors.

Authors:  Andreas Dietz; Andreas Boehm; Christian Mozet; Gunnar Wichmann; Athanassios Giannis
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-07       Impact factor: 2.503

10.  Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.

Authors:  Nam P Nguyen; Paul Vos; Howard Lee; Thomas L Borok; Ulf Karlsson; Tomas Martinez; James Welsh; Deirdre Cohen; Russell Hamilton; Nga Nguyen; Ly M Nguyen; Vincent Vinh-Hung
Journal:  Oncology       Date:  2008-10-08       Impact factor: 2.935

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.